NDC product
DNA Pancreas Formula
NDC 83027-0302 · Nutritional Specialties, Inc.
Key facts
| Product NDC | 83027-0302 |
|---|---|
| Proprietary name | DNA Pancreas Formula |
| Nonproprietary name | Lycopodium Clavatum, Pancreas Suis, DNA, Insulinum (Human), Phosphoricum Acidum, Radium Bromatum, Uranium Nitricum |
| Substances | LYCOPODIUM CLAVATUM SPORE, SUS SCROFA PANCREAS, HERRING SPERM DNA, INSULIN HUMAN, PHOSPHORIC ACID, RADIUM BROMIDE, URANYL NITRATE HEXAHYDRATE |
| Dosage form | SPRAY |
| Route | ORAL |
| Labeler | Nutritional Specialties, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Insulin [CS], Insulin [EPC] |
| Marketing start | Apr 2, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: